Collectively, these data indicate that combined heterozygosity for Ddx41 and Trp53 drives a highly penetrant hematologic malignancy phenotype that is often characterized by stem cell expansion, anemia, and thrombocytopenia, and can transform into leukemia in some instances. Here, DDX41 is linked to leukemia.